The effect of cycloheximide administration on vitamin K-stimulated prothrombin formation.
D000818:Animals; D001798:Blood Proteins / Q000096:biosynthesis; D003513:Cycloheximide / Q000494:pharmacology*; D004790:Enzyme Induction; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D008660:Metabolism / Q000187:drug effects; D011516:Prothrombin / Q000096:biosynthesis*; D051381:Rats; D013997:Time Factors; D014444:Tyrosine Transaminase / Q000096:biosynthesis; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010837:Vitamin K 1 / Q000378:metabolism; D014813:Vitamin K Deficiency / Q000378:metabolism
D001798:Blood Proteins; D014812:Vitamin K; D010837:Vitamin K 1; D011516:Prothrombin; D003513:Cycloheximide; D014444:Tyrosine Transaminase; D006854:Hydrocortisone